2008-January Archives by Subject

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...

Starting: Fri Jan 4 12:53:01 2008
Ending: Thu Jan 31 10:21:35 2008
Messages: 78

• [Ip-health] =?WINDOWS-1252?Q?Has_the_Idea_of_Open_Collaborative_Innovation_Come?= =?WINDOWS-1252?Q?_of_Age=3F_=96_A_Focus_on_the_World_Economic_Forum_2008?=   Sisule Musungu
• [Ip-health] Abbott obtains a CL on hepatitis C patent   Judit Rius Sanjuan
• [Ip-health] Activists want panel's decision on Aluvia drug reviewed   Kannikar KIJTIWATCHAKUL
• [Ip-health] ADIN pipelines- IP-Watch   Renata Reis
• [Ip-health] Alert: Tomorrow 1st Cir. Prescription Datamining Case   Sean Flynn
• [Ip-health] Antitrust: Commission launches sector inquiry into pharmaceuticals with unannounced inspections   Michelle Childs
• [Ip-health] AP: Researchers Add to HIV Protein List In Step Toward Finding New Drugs   Thiru Balasubramaniam
• [Ip-health] Big Idea paper on prizes is now published in the Chicago-Kent Law Review   James Love
• [Ip-health] Big Pharma Spends More On Advertising Than Research And Development, Study Finds   Mauricio Guaragna
• [Ip-health] BIO's Greenwood: Thailand's Patent Fight Will Fail   Sarah Rimmington
• [Ip-health] Biotech wants to be free, a Review of Biobazaar   James Love
• [Ip-health] Boehringer refuses to register tipranavir   Sean Flynn
• [Ip-health] Boehringer refuses to register tipranavir in Brazil because of patent law   =?ISO-8859-1?Q?michel lotrowska?=
• [Ip-health] Business Standard: Cancer drug puts license, patent rules to test   Mike Palmedo
• [Ip-health] Can anyone offer an update on CIPIH?   Amy Nunn
• [Ip-health] Canadian Press: Canadian Program to Ship AIDS Drugs Criticized   Mike Palmedo
• [Ip-health] Cancer drug puts licence, patent rules to test   Adrienne.MacDONALD@geneva.msf.org
• [Ip-health] David Reynolds presentation on the Medical Innovation Prize Fund (S.2210)   James Love
• [Ip-health] DNDi's R&D Efforts on Sleeping Sickness Highlighted Today in the New York Times   Ann-Marie Sevcsik
• [Ip-health] Economist: The bitterest pill   Jean Blaylock
• [Ip-health] El Pais: Salud, Pobreza y Patentes   Judit Rius Sanjuan
• [Ip-health] Financial Times: Cash for answers   Thiru Balasubramaniam
• [Ip-health] Financial Times: Novartis profits hit by restructuring charge   Thiru Balasubramaniam
• [Ip-health] FT: Drug Demand Threatens Vital Medicinal Plants   Riaz K Tayob
• [Ip-health] FT: Tough Medicine   Judit Rius Sanjuan
• [Ip-health] Fwd: [uaem-cc] Slate: Invent a Drug, Win $1 Million   Matt Price
• [Ip-health] generic pharmaceutical prices among US retailers   David Serafino
• [Ip-health] Global Fund to Fight AIDS, Tuberculosis and Malaria Launches Corporate Champions Program   Joana Ramos
• [Ip-health] Global Health & Development Conference at Yale   Jennifer.Staple@aya.yale.edu
• [Ip-health] Global pharma firms take a tropical dose   Sarah Rimmington
• [Ip-health] Health24.com on South African competition complaint over efavirenz   Mike Palmedo
• [Ip-health] Indian company requests CL to export Roche cancer drug   Judit Rius Sanjuan
• [Ip-health] International Herald Tribune: European antitrust regulators raid drug companies   Thiru Balasubramaniam
• [Ip-health] IP Competition Research   Sean Flynn
• [Ip-health] IP conference at the University of Geneva on Feb. 15, 2008   Jacques.DeWerra@droit.unige.ch
• [Ip-health] IP Watch: US Presidential Candidates Reveal Positions On Some IP Issues   Judit Rius Sanjuan
• [Ip-health] IP-Watch: Thailand Avoids Compulsory Licence On Cancer Drug; 3 More Drugs Undecided   Thiru Balasubramaniam
• [Ip-health] Jan 28/29 KEI & UNU-MERIT Maastricht Workshop on Medical Innovation Prizes   malini.aisola@keionline.org
• [Ip-health] Managing IP: The process for appointing a new WIPO director-general is underway   Thiru Balasubramaniam
• [Ip-health] Mark you calendars: February 8 - GWU & KEI Workshop on Prizes   Judit Rius Sanjuan
• [Ip-health] MSF: US patent offices move to revoke patents on key HIV/AIDS drug could mean increased access in developing world   Buddhima Lokuge
• [Ip-health] National Institute of Mental Health Strategic Plan   gittem01@med.nyu.edu
• [Ip-health] NEW BOOK: DNA   L Guevarra
• [Ip-health] NIH Public Access Policy   Sean Flynn
• [Ip-health] Novartis faces fresh patent fight in India... re: Glivec   Joana Ramos
• [Ip-health] NYer: Buying a Cure - What business know-how can do for disease.   Matt Price
• [Ip-health] NYT Essay on Cancer Data? Sorry, Can't Have it   Manon Ress
• [Ip-health] open source biotech   Peter Drahos
• [Ip-health] Open-source model for drug discovery?   Adrienne.MacDONALD@geneva.msf.org
• [Ip-health] Parallel trade =?UTF-8?B?4oCcY29uc2lkZXJhYmxlIHJpc2vigJ0gdG8gcGF0aWVudCBzYWZldHksIA==?= =?UTF-8?B?c2F5cyBFQyA=?=   munoz@southcentre.org
• [Ip-health] Patent denied in US, but granted in India   Adrienne.MacDONALD@geneva.msf.org
• [Ip-health] Press Release: GSK & MMV New Collaboration to Investigate Novel Antimalarial Compounds   Jaya Banerji
• [Ip-health] PUBPAT NEWS: U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request   robert weissman
• [Ip-health] RE: WHO publications policy discussed at WHO Executive Board   rebecca lacroix
• [Ip-health] Report on IMS oral argument   Sean Flynn
• [Ip-health] Reuters: Doubtful U.S. will pass trade deals   Sarah Rimmington
• [Ip-health] Reuters: Roche & AIDS technology transfer to Kenya, Zimbadwe, Tanzania and Bangladesh   Judit Rius Sanjuan
• [Ip-health] Selected Innovation Prizes and Reward Programs   James Love
• [Ip-health] Should the government start handing out prizes for science breakthroughs?   heeseob nam
• [Ip-health] SpicyIP: Roche vs NATCO: India's First "Doha Style" Compulsory License?   Judit Rius Sanjuan
• [Ip-health] Statement on Thai appeal   Sean Flynn
• [Ip-health] STEM Graduate Course on Intellectual Property and Technology Transfer, April 13-16, 2008   Prabhu Ram
• [Ip-health] SUNS: WHO Board debates "global health security", climate, IPRs   Sangeeta
• [Ip-health] SUNS: WHO publications will come under committee review   Sangeeta
• [Ip-health] Thai Competition Commission Rejects Complaint   Sean Flynn
• [Ip-health] Thai HIV/AIDS Advocates to Ask Admin Court for Review of Abbott Decision   Sarah Rimmington
• [Ip-health] Thailand plans to issue 4 cancer drug compulsory licenses   robert weissman
• [Ip-health] The specter of generic competition grows   Sarah Rimmington
• [Ip-health] U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request   Daniel B. Ravicher
• [Ip-health] US PTO rejects 4 tenofovir patents from Gilead   Sandeep.Rathod@matrixlabsindia.com
• [Ip-health] USPTO TDF Patent Rejection - Reactions in India (2 news reports)   Kajal Bhardwaj
• [Ip-health] Wall Street Journal: WHO Sets Up Database To Share Facts on Bird Flu   thiru@keionline.org
• [Ip-health] WCL event: Legal Strategies to Promote Access to Medicines   Mike Palmedo
• [Ip-health] WHO Executive Board discusses avian flu issues   Sangeeta
• [Ip-health] WHO Executive Board: WHO publications   thiru@keionline.org
• [Ip-health] WHO IGWG 2nd session scheduled for April 2008 possibility of NGO participation   Thiru Balasubramaniam
• [Ip-health] WSJ: Pfizer Seeks to Prevent HIV   Matt Price
• [Ip-health] WSJ: pharma suppressing data on   Ashwin Vasan

Last message date: Thu Jan 31 10:21:35 2008
Archived on: Thu Jan 31 10:21:36 2008

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...